Conversely, in those BC cell lines tamoxifen-sensitive, the co-repressors N-CoR and SMRT are preferentially recruited to the TFF1 gene promoter, which in turn results in inhibition of gene expression of ER-responsive genes (Figure 2). The gene discussed is ESR1; the disease is breast cancer.